ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0446

A Balancing Act: The Interplay Between Resilience and Frailty in Rheumatoid Arthritis

Hannah Brubeck1, Kylie Riggles1, Adrienne Tanus1, Nadine El-ayache2, George Mount2, Elizabeth Wahl2, Courtney Loecker3, Jose Garcia4, Dolores Shoback5, Joshua Baker6, Patti Katz7, Ariela Orkaby8 and Katherine Wysham9, 1VA Puget Sound Health Care System, Seattle, WA, 2VA Puget Sound Health Care System & University of Washington, Seattle, WA, 3University of Nebraska Medical Center, Omaha, 4VA Puget Sound Health Care System, VA GRECC, and University of Washington, Seattle, WA, 5San Francisco VA Medical Center & University of California San Francisco, San Francisco, CA, 6University of Pennsylvania, Philadelphia, PA, 7UCSF, San Rafael, CA, 8VA Boston Healthcare System & Division of Aging, Brigham and Women’s Hospital, Harvard Medical School & VA Geriatrics Research Education and Clinical Center, Boston, MA, 9VA PUGET SOUND/UNIVERSITY OF WASHINGTON, Seattle, WA

Meeting: ACR Convergence 2025

Keywords: Aging, physical function, psychosocial factors, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: (0430–0469) Rheumatoid Arthritis – Diagnosis, Manifestations, and Outcomes Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Frailty, a state of decreased physiological reserve and heightened vulnerability to stressors, occurs prematurely in rheumatoid arthritis (RA) and is associated with poor health outcomes. The concept of “resilience,” defined as the ability to draw on internal and external resources to cope with stress, is inversely associated with frailty in the general population. We evaluated the relationship between resilience and frailty in RA.

Methods: Data were from a single-center RA longitudinal cohort. The outcome, frailty, was measured using the Fried Frailty Phenotype (FFP)1 which assessed hand grip strength, exhaustion, walking, physical activity, and weight loss. The FFP was categorized as robust, prefrail, and frail. The predictor, resilience, was measured using the Resilience In Midlife (RIM) questionnaire2 and assessed self-efficacy (0-40), coping/adaptability (0-16), perseverance (0-16), internal locus of control (0-12), and family/social support (0-28); total scores ranged 0-100, with higher scores indicating greater resilience. Scores were divided by 10 and grouped into tertiles to describe the cohort. Patient-reported behavioral characteristics including stress, anxiety, depression, sleep, and cognition were also collected. Unadjusted and adjusted ordinal logistic regression was used to assess the cross-sectional relationship between continuous resilience score and frailty level. These models were repeated to assess the relationship between the individual resilience category scores and frailty level. Models were adjusted for age and sex.

Results: 127 participants were included, aged 64.5±11.8 years, 73% male, and 71% White (Table 1). Those in the lowest resilience tertile had numerically greater pain (5.5±2.5 vs. 3.7±3.6), stress (7.2±2.9 vs 2.0±1.9) and sleep scores (1.4±0.8 vs 0.7±0.8) and were more likely to be exhausted (76% vs. 29%) than the highest tertile. Those who had low resilience also had higher prednisone dosage (1.1±3.5 mg vs. 0.5±1.5 mg) and were more likely to be on bDMARDs (61% vs 46%) than those with high resilience. For every 10% increase in resilience, the odds of being in a higher frailty category decreased by 40% (aOR: 0.60 [0.46-0.78] p< 0.001) (Table 2). Although all resilience categories had an inverse relationship with frailty, only the coping/adaptability (aOR 0.12, p< 0.001), perseverance (aOR 0.16, p=0.004), and self-efficacy (aOR 0.33, p< 0.001) categories reached statistical significance (Figure 1).

Conclusion: Greater resilience was associated with a lower odds of physical frailty in RA, suggesting that coping strategies and the ability to utilize internal resources to cope with stress may be protective against frailty. Future work should examine the longitudinal relationship between resilience and frailty.Fried, L.P. et al. J Gerontol A Biol Sci Med Sci. 2001Ryan, L. and Caltabiano, M.L. Asian Social Science. 2009.

Supporting image 1Table 1. Participant demographics, rheumatoid arthritis disease characteristics, frailty, and behavioral characteristics, stratified by resilience score tertile (N&#3f127).

Supporting image 2Table 2. Unadjusted and adjusted ordinal logistic regression models evaluating the association of resilience score and frailty level (N&#3f127).

Supporting image 3Figure 1. Multivariable ordinal logistic regressions evaluating the association between resilience category and frailty status (N&#3f127). Odds ratios represent odds of higher frailty level per unit increase in the resilience category. Models are adjusted for age and sex. Resilience category scores were each divided by 10.


Disclosures: H. Brubeck: None; K. Riggles: None; A. Tanus: None; N. El-ayache: None; G. Mount: None; E. Wahl: None; C. Loecker: None; J. Garcia: Aveo Oncology, 2, Catalym, 2, Pfizer, 5; D. Shoback: None; J. Baker: None; P. Katz: None; A. Orkaby: None; K. Wysham: None.

To cite this abstract in AMA style:

Brubeck H, Riggles K, Tanus A, El-ayache N, Mount G, Wahl E, Loecker C, Garcia J, Shoback D, Baker J, Katz P, Orkaby A, Wysham K. A Balancing Act: The Interplay Between Resilience and Frailty in Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/a-balancing-act-the-interplay-between-resilience-and-frailty-in-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-balancing-act-the-interplay-between-resilience-and-frailty-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology